Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Voting Common Stock, par value $0.0001 per share
-
Shares outstanding
-
27.8M
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
12.5M
-
Shares change
-
-520K
-
Total reported value, excl. options
-
$69.5M
-
Value change
-
-$2.54M
-
Put/Call ratio
-
1.89
-
Number of buys
-
32
-
Number of sells
-
-35
-
Price
-
$5.55
Significant Holders of Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (JSPR) as of Q2 2025
88 filings reported holding JSPR - Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share as of Q2 2025.
Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (JSPR) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.5M shares
of 27.8M outstanding shares and own 45.02% of the company stock.
Largest 10 shareholders include Soleus Capital Management, L.P. (1.49M shares), Velan Capital Investment Management LP (1.43M shares), Carlyle Group Inc. (1.07M shares), QIMING U.S. VENTURES MANAGEMENT, LLC (929K shares), MORGAN STANLEY (770K shares), T. Rowe Price Investment Management, Inc. (704K shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (685K shares), VANGUARD GROUP INC (625K shares), Integral Health Asset Management, LLC (590K shares), and Rock Springs Capital Management LP (545K shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.